AMLX Dividend History & Analysis | Yield
AMLX has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| BMY NYSE Bristol-Myers Squibb |
127,714 M | 4.38% | 5.28% |
| TAK NYSE Takeda Pharmaceutical |
63,923 M | 3.83% | 6.09% |
| NVS NYSE Novartis |
294,776 M | 3.06% | 6.85% |
| GSK NYSE GlaxoSmithKline |
97,531 M | 3.53% | 5.22% |
| NOVN SW Novartis |
295,786 M | 2.99% | 6.16% |
| VTRS NASDAQ Viatris |
21,226 M | 3.50% | 4.29% |
| ORNBV HE Orion |
15,472 M | 2.38% | 5.67% |
| MRK NYSE Merck |
361,021 M | 2.89% | 4.51% |
| HLUN-B CO H Lundbeck |
7,747 M | 3.08% | 3.49% |
| ROP SW Roche Holding |
377,484 M | 3.05% | 3.23% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
7,747 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
6,581 M | 26.84% | 99.0% |
| FAGR BR Fagron |
1,930 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,224,985 M | 15.24% | 100.0% |
| NVS NYSE Novartis |
294,776 M | 8.79% | 100.0% |
| MRK NYSE Merck |
361,021 M | 5.34% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
37,421 M | 5.31% | 100.0% |
| IPN PA Ipsen |
14,116 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
644,913 M | 4.72% | 100.0% |
| NOVN SW Novartis |
295,786 M | 4.53% | 100.0% |
AMLX Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
AMLX Dividend FAQ
As of October 2026, AMLX's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 28.86.
As of October 2026 AMLX does not pay a dividend.
Over the last 12 months, AMLX has issued dividend payments.
Based on historical data, the forecasted dividends per share for AMLX for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Amylyx Pharmaceuticals (AMLX) is currently unknown.
The next Ex-Dividend date for Amylyx Pharmaceuticals (AMLX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
AMLX's average dividend growth rate over the past 5 years is -% per year.
AMLX's 5-Year Yield on Cost is -%. If you bought AMLX's shares at 18.07 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
AMLX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
AMLX's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of AMLX is unknown.
AMLX's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
AMLX Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-10-21 02:37 UTC